DG Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$8.37M |
| 2 |
VEON
VEON
|
+$4.14M |
| 3 |
Hertz
HTZ
|
+$2.77M |
| 4 |
Community Health Systems
CYH
|
+$2.61M |
| 5 |
Tenet Healthcare
THC
|
+$2.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$9.91M |
| 2 |
Turning Point Brands
TPB
|
+$6.14M |
| 3 |
Anterix
ATEX
|
+$4.08M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$2.84M |
| 5 |
Burford Capital
BUR
|
+$2.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.59% |
| 2 | Consumer Discretionary | 26% |
| 3 | Industrials | 12.06% |
| 4 | Communication Services | 7.18% |
| 5 | Financials | 6.27% |
Similar funds
DG Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, DG Capital Management held 38 positions worth $183M, down 18% from $224M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
DG Capital Management withdrew a net $21.6M in Q3 2023, closing 12 positions and reducing 4 holdings. Its most notable exit was Intercept Pharmaceuticals, Inc., an estimated $9.91M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, DG Capital Management added an estimated $8.37M to United Therapeutics.
- DG Capital Management added most to United Therapeutics in Q3 2023, an estimated $8.37M increase.
- DG Capital Management's biggest Q3 2023 reduction was Burford Capital, cutting an estimated $2.07M.
- DG Capital Management fully exited Intercept Pharmaceuticals, Inc. in Q3 2023, selling an estimated $9.91M.
- DG Capital Management's ten largest holdings make up 77% of its $183M portfolio in Q3 2023.
- DG Capital Management opened 2 new positions and closed 12 in Q3 2023.
- DG Capital Management's portfolio value fell 18% quarter-over-quarter to $183M.
Based on DG Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.